Evidence map›Paper›PMID 37059930›Full record

ArticleInternational journal of hematology2023

Identification of a novel mutation in the factor XIII A subunit in a patient with inherited factor XIII deficiency.

Lijie Yan, Tiantian Wang, Jihua Qiu, Xinsheng Zhang, Jun Peng, Yunhai Fang, Zi Sheng

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Lijie Yan *Department of Hematology, Qilu Hospital of Shandong University, No. 107 Wenhua West Road, Jinan, China.
Tiantian Wang *Shandong Blood Center, Shandong Hemophilia Treatment Center, No. 22, Shanshi East Road, Jinan, China.
Jihua QiuDepartment of Geriatric Medicine, Qilu Hospital of Shandong University, Jinan, China.
Xinsheng ZhangShandong Blood Center, Shandong Hemophilia Treatment Center, No. 22, Shanshi East Road, Jinan, China.
Jun PengDepartment of Hematology, Qilu Hospital of Shandong University, No. 107 Wenhua West Road, Jinan, China.
Yunhai FangShandong Blood Center, Shandong Hemophilia Treatment Center, No. 22, Shanshi East Road, Jinan, China. fyhhbln@163.com.
Zi ShengDepartment of Hematology, Qilu Hospital of Shandong University, No. 107 Wenhua West Road, Jinan, China. 18253161059@163.com.ORCID http://orcid.org/0000-0002-2884-4462
Qilu Hospital of Shandong University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNShandong Mental Health Center · CN

Funding

China Postdoctoral Science Foundation 2020M672075National Natural Science Foundation of China 81770133National Natural Science Foundation of China 82000126National Natural Science Foundation of China 91942306Shandong Medical and Health Science and Technology Development Program 202103040601
6 · The paper itself

Abstract

Inherited factor XIII (FXIII) deficiency is an extremely rare and under-diagnosed autosomal recessive inherited coagulopathy, which is caused by genetic defects in the F13A1 or F13B gene. More than 200 genetic mutations have been identified since the first case of inherited FXIII deficiency was reported. This study aimed to identify underlying gene mutations in a patient with inherited FXIII deficiency who presented with recurrent intracerebral hemorrhage. Levels of plasma FXIII-A antigen were measured, F13A1 and F13B genes were sequenced, mutation information was analyzed, and the mutated protein structure was predicted using bioinformatics methods. Molecular genetic analysis identified four mutations of FXIII-related genes in the proband, including three previously reported mutations inherited from his parents (c.631G>A, p.Gly210Arg and c.1687G>A, p.Gly562Arg of F13A1 gene and c.344G>A, p.Arg115His of F13B gene) and a novel spontaneous mutation of F13A1 gene (c.2063C>G, p.Ser687Cys). Molecular structural modeling demonstrated that the novel Ser687Cys mutation may cause changes in the spatial structure of FXIII-A and increase its instability. In conclusion, we identified a novel and likely pathogenic mutation of the F13A1 gene, which enriched the gene mutation spectrum of inherited FXIII deficiency. The findings may provide promising targets for diagnosis and treatment of inherited FXIII deficiency.

Indexed as

Factor XIIIaFactor XIII DeficiencyFactor XIIIHemorrhageHumansMutationFactor XIIIFactor XIIIaCoagulation factor XIIICompound heterozygoteF13A1 geneInherited FXIII deficiencyMissense mutation

Identifiers

PMID37059930
OpenAlexW4365504688

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.